General discussion, page-1994

Really interesting points being made about the 5000 dose batch of HCQ that has just arrived for the company.

I concur that it is likely that the combination study done by Eurofins Taiwan has gone well and that the company is likely to proceed into a human trial. Why else would you need that much HCQ?

However, when applying for the FDA for EUA the completion of our two part pre-clinical study will be enough to warrant an application according to Camargo. We dont technically have to have done a human trial in order for the FDA to approve us for EUA.

The likely best outcome for IHL is to have been granted FDA EUA for IHL-675A and concurrently running a human trial for it. With the cash balance we have post-oppies expiry this can be done with ease. Now waiting to see those results back... as well as how patient recruitment for OSA is going.

Surely it would start this year.